Not checkedNot checked for notices yet.
SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
Janeri Fröberg, Joshua Gillard, Ria Philipsen and 16 more
Nature Communications · 2021
doi:10.1038/s41467-021-25949-x (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
There has been limited research on the role of the mucosal immune response to SARS-CoV-2 infection. Here, the authors perform a prospective observational household study and find that mucosal antibody responses are associated with decreased viral load and faster resolution of systemic symptoms.
Abstract licence: CC BY-NC-ND
References71
- 4.
- 13.Expression of concern
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR · 2020
- 25.
- 29.Corrected
A human monoclonal antibody blocking SARS-CoV-2 infection · 2020
- 34.
- 35.
- 40.
33 more references, whose wording the paper’s licence keeps private.
All 71 referencesReads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.